Ibandronate Sodium
NDC 65862-237, Ibandronate Sodium, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 65862-237
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204502
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBANDRONATE SODIUM150 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-237-03 | 65862023703 | 1 BLISTER PACK in 1 CARTON (65862-237-03) / 3 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/86c0b4ae-5e38-4efe-88af-50ac560e294fNADAC price for package 65862023703
GET /v1/drugs/nadac/65862023703
Use it
Look up 65862-237 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.